Big Molecule Watch
- FDA Approves Celltrion’s Aflibercept Biosimilar October 14, 2025 Riley Wyberg
- Amgen and Biocon Settle Denosumab BPCIA Case October 14, 2025 Christopher Cassella
- Celltrion Announces Launch of AVTOZMA® (tocilizumab-anoh) Intravenous Formulation in the United States October 13, 2025 Tara Thigpen
- Kashiv BioSciences Omalizumab Biosimilar Application Submitted to FDA, Accepted by EMA October 9, 2025 Zachariah Holmes
- Biogen Ordered to Pay Genentech $88.3 Million in Past Royalties on Cabilly Patents October 7, 2025 Darlene Staines
- PTAB Issues Four IPR Written Decisions in Merck and Johns Hopkins Pembrolizumab Dispute October 6, 2025 Darlene Staines
- Amgen and Samsung Bioepis Settle Denosumab BPCIA Case October 6, 2025 Darlene Staines
- Court Denies Amgen Motion to Dismiss in Etanercept Antitrust Case October 6, 2025 Darlene Staines
- FDA Approves Seventh Denosumab Biosimilar: Richter and Hikma’s Enoby and Xtrenbo October 2, 2025 Harrison Gunn
- Aflibercept BPCIA Multi-District Litigation Updates September 30, 2025 Gabriella Montes